Claire E. Wainwright

Claire E. Wainwright

62 Graham St
South Brisbane, QLD 4101, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 141 publications

Multiple defects in macrophage antibacterial responses support intracellular survival of Mycobacterium abscessus in cystic fibrosis.

Multiple defects in macrophage antibacterial responses support intracellular survival of Mycobacterium abscessus in cystic fibrosis.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: May 27, 2026

The cystic fibrosis gut microbial dysbiosis index (CF-GMDI): a quantitative measure of gut microbial imbalance in children with cystic fibrosis.

The cystic fibrosis gut microbial dysbiosis index (CF-GMDI): a quantitative measure of gut microbial imbalance in children with cystic fibrosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: February 17, 2026

Is the gut a reservoir of non-tuberculous mycobacteria in people with cystic fibrosis?

Is the gut a reservoir of non-tuberculous mycobacteria in people with cystic fibrosis?

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: January 26, 2026

Lumacaftor-Ivacaftor in Pediatric Patients With Cystic Fibrosis and Advanced Liver Disease: A Pilot Study.

Lumacaftor-Ivacaftor in Pediatric Patients With Cystic Fibrosis and Advanced Liver Disease: A Pilot Study.

Journal: Clinical therapeutics

Published: December 20, 2025

Reply to Yang and Zeng: Durability or bias? Reconsidering long-term ELX/TEZ/IVA outcomes in children with CF.

Reply to Yang and Zeng: Durability or bias? Reconsidering long-term ELX/TEZ/IVA outcomes in children with CF.

Journal: American journal of respiratory and critical care medicine

Published: September 23, 2025

Improvements in health-related quality of life in people with cystic fibrosis ≥6 years of age treated with vanzacaftor/tezacaftor/deutivacaftor.

Improvements in health-related quality of life in people with cystic fibrosis ≥6 years of age treated with vanzacaftor/tezacaftor/deutivacaftor.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: September 22, 2025

Finding the optimal regimen for Mycobacteroides abscessus treatment (FORMaT) in people with Mycobacteroides abscessus pulmonary disease: a multicentre, randomised, multi-arm, adaptive platform trial.

Finding the optimal regimen for Mycobacteroides abscessus treatment (FORMaT) in people with Mycobacteroides abscessus pulmonary disease: a multicentre, randomised, multi-arm, adaptive platform trial.

Journal: BMJ open

Published: September 21, 2025

Evaluating Long-Term Effectiveness of Cystic Fibrosis Modulator Therapies After Rapid Adoption: A Dual-Approach Study.

Evaluating Long-Term Effectiveness of Cystic Fibrosis Modulator Therapies After Rapid Adoption: A Dual-Approach Study.

Journal: Annals of the American Thoracic Society

Published: September 08, 2025

Hitting the Sweet Spot: The Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance in Cystic Fibrosis.

Hitting the Sweet Spot: The Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance in Cystic Fibrosis.

Journal: American journal of respiratory and critical care medicine

Published: August 22, 2025

Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children ≥6 Years with Cystic Fibrosis and at Least One F508del Allele: A 192-Week, Phase 3, Open-Label Extension Study.

Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children ≥6 Years with Cystic Fibrosis and at Least One F508del Allele: A 192-Week, Phase 3, Open-Label Extension Study.

Journal: American journal of respiratory and critical care medicine

Published: June 02, 2025

Successful off-label use of elexacaftor/tezacaftor/ivacaftor in an infant with severe CF disease.

Successful off-label use of elexacaftor/tezacaftor/ivacaftor in an infant with severe CF disease.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: May 11, 2025

The changing face of cystic fibrosis research: challenges of multi-centre microbiology cohort studies.

The changing face of cystic fibrosis research: challenges of multi-centre microbiology cohort studies.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: April 27, 2025

Showing 1-12 of 141

Last Updated: 09/26/2026